- 1) Kamat AM and Lamm DL, Urology, 55, 161–168 (2000).
- 2) Kasof GM and Gomes BC, J. Biol. Chem., 276, 3238–3246 (2001).
- 3) Ma L, Huang Y, Song Z, Feng S, Tian X, Du W, Qiu X, Heese K, and Wu M, Cell Death. Differ., 13, 2079–2088 (2006).
- 4) Wang L, Zhang Q, Liu B, Han M, and Shan B, Mol. Cancer Ther., 7, 3661–3669 (2008).
- 5) Kumar S, Cell Death. Differ., 14, 32–43 (2007).
- 6) Liu B, Han M, Wen JK, and Wang L, Cancer Lett., 250, 168–176 (2007).
- 7) Crnkovic-Mertens I, Hoppe-Seyler F, and Butz K, Oncogene, 22, 8330–8336 (2003).
- 8) Wang R, Lin F, Wang X, Gao P, Dong K, Zou AM, Cheng SY, Wei SH, and Zhang HZ, Cancer Gene Ther., 15, 402–412 (2008).
- 9) Liu HB, Kong CZ, Zeng Y, Liu XK, Bi JB, Jiang YJ, and Han S, Urol. Oncol., 27, 277–283 (2008).
- 10) Gazzaniga P, Gradilone A, Giuliani L, Gandini O, Silvestri I, Nofroni I, Saccani G, Frati L, and Agliano AM, Ann. Oncol., 14, 85–90 (2003).
- 11) Fuchs U, mm-Welk C, and Borkhardt A, Curr. Mol. Med., 4, 507–517 (2004).
- 12) Moazed D, Nature, 457, 413–420 (2009).
- 13) Kim D and Rossi J, Biotechniques, 44, 613–616 (2008).
- 14) Fischer U and Schulze-Osthoff K, Pharmacol. Rev., 57, 187–215 (2005).
- 15) LaCasse EC, Mahoney DJ, Cheung HH, Plenchette S, Baird S, and Korneluk RG, Oncogene, 27, 6252–6275 (2008).
- 16) Wang H, Tan SS, Wang XY, Liu DH, Yu CS, Bai ZL, He DL, and Zhao J, Acta Pharmacol. Sin., 28, 1968–1974 (2007).
- 17) Fedorov Y, Anderson EM, Birmingham A, Reynolds A, Karpilow J, Robinson K, Leake D, Marshall WS, and Khvorova A, RNA, 12, 1188–1196 (2006).
- 18) Scherer LJ and Rossi JJ, Nat. Biotechnol., 21, 1457–1465 (2003).
- 19) Reynolds A, Anderson EM, Vermeulen A, Fedorov Y, Robinson K, Leake D, Karpilow J, Marshall WS, and Khvorova A, RNA, 12, 988–993 (2006).
- 20) Franken NA, Rodermond HM, Stap J, Haveman J, and van Bree C, Nat. Protoc., 1, 2315–2319 (2006).
- 21) Wu KY, Wang HZ, and Hong SJ, Mol. Vis., 14, 1705–1712 (2008).
- 22) Pai SI, Lin YY, Macaes B, Meneshian A, Hung CF, and Wu TC, Gene Ther., 13, 464–477 (2006).
- 23) Wang L, Fuqing Z, Zheng L, and Tong Q, J. Huazhong Univ. Sci. Technolog Med. Sci., 26, 317–318, 328 (2006).
- 24) Zhao JH, Yang CT, Wu JW, Tsai WB, Lin HY, Fang HW, Ho Y, and Liu HL, J. Biomol. Struct. Dyn., 26, 65–74 (2008).
- 25) Ashkenazi A, Cytokine Growth Factor Rev., 19, 325–331 (2008).
- 26) Crnkovic-Mertens I, Semzow J, Hoppe-Seyler F, and Butz K, J. Mol. Med., 84, 232–240 (2006).
- 27) Ashhab Y, Alian A, Polliack A, Panet A, and Ben YD, FEBS Lett., 495, 56–60 (2001).
- 28) Hou JQ, He J, Wen DG, and Wang XL, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 24, 401–404 (2007).
- 29) Bilim V, Kasahara T, Hara N, Takahashi K, and Tomita Y, Int. J. Cancer, 103, 29–37 (2003).
- 30) Zhao YZ, Luo YK, Lu CT, Xu JF, Mei XG, Wang HJ, and Zhang M, Yao Xue Xue Bao, 42, 1323–1326 (2007).
- 31) Feril JrLB, Ogawa R, Tachibana K, and Kondo T, Cancer Sci., 97, 1111–1114 (2006).
Full access
Suppression of Livin Gene Expression by siRNA Leads to Growth Inhibition and Apoptosis Induction in Human Bladder Cancer T24 Cells
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.